Although a subset of patients can be cured with liver transplants, and a drug that could slow the disease somewhat was approved in Europe, there were no truly effective treatments for the majority of patients with this disease in the United States. Above: representation of abnormal amyloid buildup that clings to nerves, as it happens in transthyretin amyloidosis.